Literature DB >> 31339515

Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.

Grace K Sohn1, Gina P Kwon1, Irene Bailey-Healy1, Amar Mirza1,2, Kavita Sarin1, Anthony Oro1,2, Jean Y Tang1.   

Abstract

Entities:  

Year:  2019        PMID： 31339515      PMCID： PMC6659355          DOI： 10.1001/jamadermatol.2019.1541

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  2 in total

1.  A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome).

Authors:  B J A Verkouteren; B Cosgun; M G H C Reinders; P A W K Kessler; R J Vermeulen; M Klaassens; S Lambrechts; J R van Rheenen; M van Geel; M Vreeburg; K Mosterd
Journal:  Br J Dermatol       Date:  2021-11-08       Impact factor: 11.113

Review 2.  Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma.

Authors:  Olivia M Chen; Keemberly Kim; Chelsea Steele; Kelly M Wilmas; Nader Aboul-Fettouh; Carrick Burns; Hung Quoc Doan; Sirunya Silapunt; Michael R Migden
Journal:  Cancers (Basel)       Date:  2022-07-30       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.